Paul Wicks is a seasoned professional with a strong background in investing in UK/EU-based companies specializing in digital health solutions aimed at improving patient outcomes. His strategic investments in companies like BlueSkye AI, EarSwitch, Sano Genetics, and Una Health underscore his keen eye for promising ventures. Beyond his investment acumen, Paul has excelled as an R&D Director, leading teams in research, industry collaborations, and patient engagement initiatives. His academic pursuits, including postdoctoral work on Parkinson's disease and a PhD focusing on cognitive dysfunction in individuals with amyotrophic lateral sclerosis, highlight his expertise in the healthcare domain. With a diverse skill set encompassing statistical analysis, publication in peer-reviewed journals, and web management, Paul demonstrates versatility across scientific and business realms.
Areas of Expertise
AI, Amyotrophic Lateral Sclerosis, Angel Investing, Cognition and Learning, Depression and the pursuit of mental health, Digital Health, Executive Function, Health 2.0, Humanitarian Efforts, Neuropsychology, Online Communities, Public Health, Rare Diseases